mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
6e-07 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-06 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0006 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0007 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.002 |